Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Pre-op Rectal ChemoRad +/- Cetuximab

ClinicalTrials.gov ID: NCT00527111

Public ClinicalTrials.gov record NCT00527111. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum

Study identification

NCT ID
NCT00527111
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Oncology Research
Industry
Enrollment
139 participants

Conditions and interventions

Conditions

Interventions

  • Cetuximab Drug
  • 5-fluorouracil Drug
  • Pelvic irradiation Radiation

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2007
Primary completion
Dec 31, 2014
Completion
Dec 31, 2014
Last update posted
Nov 2, 2016

2007 – 2015

United States locations

U.S. sites
41
U.S. states
15
U.S. cities
39
Facility City State ZIP Site status
Oncology Associates D.B.A. Hematology Oncology Physicians & Extenders Tucson Arizona 85704
Melbourne Internal Medicine Associates Melbourne Florida 32901
Advanced Medical Specialties Miami Florida 33133
Cancer Centers of Florida, P.A. Ocoee Florida 34761
Cancer Care & Hematology Specialists of Chicagoland, PC Niles Illinois 60714
Central Indiana Cancer Centers Indianapolis Indiana 76227
Kansas City Cancer Centers-Southwest Overland Park Kansas 66210
Alliance Hematology Oncology PA Westminster Maryland 21157
Missouri Cance Associates Columbia Missouri 65201
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
New York Oncology Hematology, P.C. Albany New York 12206
Cancer Centers of North Carolina Raleigh North Carolina 27607
Willamette Valley Cancer Center Eugene Oregon 97401
Texas Oncology - Amarillo Amarillo Texas 79106
Texas Oncology Cance Center Austin Texas 78731
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702
Texas Cancer Center at Medical City Dallas Texas 75230
Methodist Charlton Cancer Ctr. Dallas Texas 75237
Texas Oncology, P.A. Dallas Texas 75246
Texas Cancer Center Denton Texas 76210
El Paso Cancer Treatment Ctr El Paso Texas 79915
Texas Oncology, P.A. Fort Worth Texas 76104
Lake Vista Cancer Center Lewisville Texas 75067
Longview Cance Center Longview Texas 75601
Allison Cancer Center Midland Texas 79701
Texas Oncology-Odessa Odessa Texas 79761
Paris Regional Cancer Center Paris Texas 75460
HOAST - Medical Dr. San Antonio Texas 78229
Texas Cancer Center - Sherman Sherman Texas 75090
Texas Oncology Cancer Center-Sugar Land Sugar Land Texas 77479
Tyler Cancer Center Tyler Texas 75702
Texas Oncology Cancer Care and Research Waco Texas 76712
Texas Oncology, P.A. Webster Texas 77598
Texoma Cancer Center Wichita Falls Texas 76310
Virginia Oncology Associates Norfolk Virginia 23502
Highline Medical Oncology Burien Washington 98166
Cancer Care Northwest-South Spokane Washington 99202
Northwest Cancer Specialists-Vancouver Vancouver Washington 98684
Yakima Valley Mem Hosp/North Star Lodge Yakima Washington 98902
Raleigh Regional Cancer Center Beckley West Virginia 25801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00527111, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00527111 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →